http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104945411-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43d2eb7ccd1f952dc366fe00ae26236d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeed44bb58a28353d44a06234652b94c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323fe70e5a5c3cb104048718e4e52ed8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7968f3d07e6bc25545af60b86e9247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbea97868188848f50db7ee6665f5e8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64189cb91a09d21f88b40960c3d1f563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5902ee58bab9148039dedf3129f575e2
publicationDate 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104945411-A
titleOfInvention Thieno[3,2-c]pyridine compounds, their preparation method and application
abstract The present invention relates to a class of thieno[3,2-c]pyridine compounds and applications thereof, which have a structure of formula (I). The compound of the present invention whose structure is represented by formula (I) has a good inhibitory effect on Bruton kinase activity, and the present invention also relates to the use of such compounds in the prevention and/or treatment of BTK (Bruton tyrosine kinase) activity inhibition And improve the application of the disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109535047-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106478473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110105268-A
priorityDate 2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103087078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005043347-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164174682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465936606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432149346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466049026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420002132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163469059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465025531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13016078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467981972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164098746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13299177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154190028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410470857

Total number of triples: 43.